Mani Foroohar
Stock Analyst at Leerink Partners
(0.90)
# 2,181
Out of 4,502 analysts
150
Total ratings
30%
Success rate
-33.38%
Average return
Main Sectors:
Top Industries:
28 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Upgrades: Outperform | $53 → $62 | $51.86 | +19.55% | 12 | Jul 24, 2024 | |
| BNTC Benitec Biopharma | Initiates: Outperform | $13 | $9.13 | +42.39% | 1 | Jul 22, 2024 | |
| SDGR Schrödinger | Initiates: Outperform | $29 | $22.29 | +30.10% | 1 | Jul 2, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Outperform | $165 → $230 | $147.56 | +55.87% | 1 | Jun 24, 2024 | |
| NGNE Neurogene | Initiates: Outperform | $46 | $42.70 | +7.73% | 1 | Apr 29, 2024 | |
| CVAC CureVac | Downgrades: Market Perform | $12 → $4 | $3.64 | +9.89% | 2 | Apr 25, 2024 | |
| MIRM Mirum Pharmaceuticals | Maintains: Outperform | $44 → $43 | $40.37 | +6.51% | 10 | Mar 18, 2024 | |
| RGNX REGENXBIO | Upgrades: Outperform | n/a | $14.39 | - | 7 | Mar 6, 2024 | |
| ENGN enGene Holdings | Initiates: Outperform | $31 | $9.00 | +244.44% | 1 | Feb 20, 2024 | |
| ALVR AlloVir | Downgrades: Market Perform | $1 | $0.77 | +30.04% | 9 | Dec 22, 2023 | |
| WVE Wave Life Sciences | Upgrades: Outperform | $12 | $6.30 | +90.48% | 4 | Dec 19, 2023 | |
| TNYA Tenaya Therapeutics | Initiates: Outperform | $7 | $3.99 | +75.44% | 1 | Nov 30, 2023 | |
| LXEO Lexeo Therapeutics | Initiates: Outperform | $19 | $11.79 | +61.15% | 1 | Nov 28, 2023 | |
| ARWR Arrowhead Pharmaceuticals | Downgrades: Market Perform | $40 | $28.94 | +38.22% | 10 | May 12, 2023 | |
| BBIO BridgeBio Pharma | Maintains: Outperform | $25 → $27 | $26.70 | +1.12% | 11 | Apr 13, 2023 | |
| FDMT 4D Molecular Therapeutics | Maintains: Market Perform | $14 → $13 | $18.52 | -29.81% | 7 | Apr 13, 2023 | |
| MRNA Moderna | Downgrades: Underperform | $111 → $93 | $120.40 | -22.76% | 16 | Feb 24, 2023 | |
| RXRX Recursion Pharmaceuticals | Maintains: Market Perform | $9 → $8 | $8.05 | -0.62% | 6 | Jan 23, 2023 | |
| RCKT Rocket Pharmaceuticals | Maintains: Outperform | $50 → $49 | $25.88 | +89.34% | 9 | Jan 23, 2023 | |
| NTLA Intellia Therapeutics | Maintains: Outperform | $86 → $84 | $26.42 | +217.94% | 4 | Jan 23, 2023 | |
| EDIT Editas Medicine | Maintains: Market Perform | $6 → $7 | $5.57 | +25.67% | 4 | Jan 23, 2023 | |
| BLUE bluebird bio | Maintains: Market Perform | $9 → $8 | $1.20 | +566.67% | 7 | Jan 23, 2023 | |
| BEAM Beam Therapeutics | Maintains: Outperform | $81 → $77 | $32.17 | +139.35% | 2 | Jan 23, 2023 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Market Perform | $144 → $143 | $237.88 | -39.89% | 8 | Jan 23, 2023 | |
| ABEO Abeona Therapeutics | Maintains: Market Perform | $5 → $6 | $5.03 | +19.28% | 4 | Nov 14, 2022 | |
| CRSP CRISPR Therapeutics AG | Maintains: Outperform | $75 → $76 | $57.57 | +32.01% | 1 | Nov 7, 2022 | |
| CRBU Caribou Biosciences | Maintains: Outperform | $30 → $34 | $2.44 | +1,293.44% | 4 | May 12, 2022 | |
| ADVM Adverum Biotechnologies | Maintains: Market Perform | $50 → $20 | $8.09 | +147.22% | 6 | Jul 23, 2021 |
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53 → $62
Current: $51.86
Upside: +19.55%
Benitec Biopharma
Jul 22, 2024
Initiates: Outperform
Price Target: $13
Current: $9.13
Upside: +42.39%
Schrödinger
Jul 2, 2024
Initiates: Outperform
Price Target: $29
Current: $22.29
Upside: +30.10%
Sarepta Therapeutics
Jun 24, 2024
Maintains: Outperform
Price Target: $165 → $230
Current: $147.56
Upside: +55.87%
Neurogene
Apr 29, 2024
Initiates: Outperform
Price Target: $46
Current: $42.70
Upside: +7.73%
CureVac
Apr 25, 2024
Downgrades: Market Perform
Price Target: $12 → $4
Current: $3.64
Upside: +9.89%
Mirum Pharmaceuticals
Mar 18, 2024
Maintains: Outperform
Price Target: $44 → $43
Current: $40.37
Upside: +6.51%
REGENXBIO
Mar 6, 2024
Upgrades: Outperform
Price Target: n/a
Current: $14.39
Upside: -
enGene Holdings
Feb 20, 2024
Initiates: Outperform
Price Target: $31
Current: $9.00
Upside: +244.44%
AlloVir
Dec 22, 2023
Downgrades: Market Perform
Price Target: $1
Current: $0.77
Upside: +30.04%
Wave Life Sciences
Dec 19, 2023
Upgrades: Outperform
Price Target: $12
Current: $6.30
Upside: +90.48%
Tenaya Therapeutics
Nov 30, 2023
Initiates: Outperform
Price Target: $7
Current: $3.99
Upside: +75.44%
Lexeo Therapeutics
Nov 28, 2023
Initiates: Outperform
Price Target: $19
Current: $11.79
Upside: +61.15%
Arrowhead Pharmaceuticals
May 12, 2023
Downgrades: Market Perform
Price Target: $40
Current: $28.94
Upside: +38.22%
BridgeBio Pharma
Apr 13, 2023
Maintains: Outperform
Price Target: $25 → $27
Current: $26.70
Upside: +1.12%
4D Molecular Therapeutics
Apr 13, 2023
Maintains: Market Perform
Price Target: $14 → $13
Current: $18.52
Upside: -29.81%
Moderna
Feb 24, 2023
Downgrades: Underperform
Price Target: $111 → $93
Current: $120.40
Upside: -22.76%
Recursion Pharmaceuticals
Jan 23, 2023
Maintains: Market Perform
Price Target: $9 → $8
Current: $8.05
Upside: -0.62%
Rocket Pharmaceuticals
Jan 23, 2023
Maintains: Outperform
Price Target: $50 → $49
Current: $25.88
Upside: +89.34%
Intellia Therapeutics
Jan 23, 2023
Maintains: Outperform
Price Target: $86 → $84
Current: $26.42
Upside: +217.94%
Editas Medicine
Jan 23, 2023
Maintains: Market Perform
Price Target: $6 → $7
Current: $5.57
Upside: +25.67%
bluebird bio
Jan 23, 2023
Maintains: Market Perform
Price Target: $9 → $8
Current: $1.20
Upside: +566.67%
Beam Therapeutics
Jan 23, 2023
Maintains: Outperform
Price Target: $81 → $77
Current: $32.17
Upside: +139.35%
Alnylam Pharmaceuticals
Jan 23, 2023
Maintains: Market Perform
Price Target: $144 → $143
Current: $237.88
Upside: -39.89%
Abeona Therapeutics
Nov 14, 2022
Maintains: Market Perform
Price Target: $5 → $6
Current: $5.03
Upside: +19.28%
CRISPR Therapeutics AG
Nov 7, 2022
Maintains: Outperform
Price Target: $75 → $76
Current: $57.57
Upside: +32.01%
Caribou Biosciences
May 12, 2022
Maintains: Outperform
Price Target: $30 → $34
Current: $2.44
Upside: +1,293.44%
Adverum Biotechnologies
Jul 23, 2021
Maintains: Market Perform
Price Target: $50 → $20
Current: $8.09
Upside: +147.22%